Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSM.TO)

Helius Medical Technologies Inc (HSM.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has provided written notice to the Toronto...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has received Breakthrough Designation...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended June...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX: HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that, effective August 10, 2021, its independent...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that the Company has launched a new website:...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the following...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Antonella Favit-Van Pelt,...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
JNJ : 164.75 (-0.28%)
TEVA : 8.99 (+0.45%)
BMY : 61.31 (+0.13%)
Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced it will participate in the Annual World Congress...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that second quarter of fiscal year 2021 financial...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff and Jeffrey S. Mathiesen...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)

Barchart Exclusives

US Stock Markets: Stop the Seasonal Madness
A popular theme on financial television these days is September is a seasonally bearish time for US stock markets. The evidence does not support this idea. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar